Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2020
2020 World Conference on Lung Cancer
Conference Program for the 2020 World Conference on Lung Cancer
Presentation Date(s):- January 28 - 31, 2021
- Total Presentations: 1597
To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.
Presentations will be available 24 hours after their live presentation time
-
+
P89 - Targeted Therapy - Clinically Focused - Translational
- Type: Posters
- Track: Targeted Therapy - Clinically Focused
- Presentations: 16
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
P89.01 - Clinical and Genomic Features of EGFR-KDD/EGFR Rearrangements of Chinese Lung Cancer Patients
00:00 - 00:00 | Presenter: Chengzhi Zhou
- Abstract
Loading... -
+
P89.02 - The Effect of Racial Diversity on the Landscape of Targetable Genomic Alterations in Patients with Lung Adenocarcinomas
00:00 - 00:00 | Author(s): Huashan Shi
- Abstract
Loading... -
+
P89.03 - Demonstrating VALUE of Liquid Biopsy for Lung Cancer in a Public Healthcare System
00:00 - 00:00 | Presenter: Desiree Hao
- Abstract
Loading... -
+
P89.04 - Real-World First Line Targeted Therapy Duration Following ctDNA Testing in Advanced Non-Small Cell Lung Cancer
00:00 - 00:00 | Author(s): Junhua Yu
- Abstract
Loading... -
+
P89.05 - Management of Patients with EGFR and ALK-Mutated Advanced Non-Small Cell Lung Cancer Post-TKI Therapy – A Real-World Survival Analysis
00:00 - 00:00 | Presenter: Kathleen Claire Kerrigan
- Abstract
Loading... -
+
P89.06 - Prospective Concordance Study of a Multi-Gene PCR Assay and NGS for the Detection of Targetable Gene Alterations in Lung Cancer
00:00 - 00:00 | Presenter: Shingo Matsumoto
- Abstract
Loading... -
+
P89.07 - A Large-Scale Survey of IDH1/2 Mutation in Chinese Patients With NSCLC
00:00 - 00:00 | Presenter: Meizi Jin
- Abstract
Loading... -
+
P89.08 - Real-World Impact of Plasma Cell-Free DNA Next-Generation Sequencing to Detect Actionable Genomic Alterations in Advanced NSCLC
00:00 - 00:00 | Presenter: Beung-Chul Ahn
- Abstract
Loading... -
+
P89.09 - The Landscape of Kinase Domain Duplication (KDD) in Chinese Lung Cancer Patients
00:00 - 00:00 | Presenter: Pingli Wang
- Abstract
Loading... -
+
P89.10 - Genomic Alteration Features and Targeted Therapy Opportunities of Primary Thoracic Sarcoma Patients
00:00 - 00:00 | Presenter: Lixia Ju
- Abstract
Loading... -
+
P89.11 - Mutational Profile of Multiple Lung Cancers in Xuanwei by Next-Generation Sequencing
00:00 - 00:00 | Presenter: Gang Guo
- Abstract
Loading... -
+
P89.12 - Real World Outcomes in EGFR-Mutant Relapsed and De Novo Stage IV Non-Small Cell Lung Cancer (NSCLC)
00:00 - 00:00 | Presenter: Amanda Jane Williams Gibson
- Abstract
Loading... -
+
P89.13 - Real-World Experience of NGS-Based Molecular Profiling in ‘Triple-Negative’ (EGFR/ALK/ROS1) Advanced NSCLC: Should we keep Testing Smokers?
00:00 - 00:00 | Presenter: Francesca Simionato
- Abstract
Loading... -
+
P89.14 - Preliminary Study on CTCs and CTECs in Non-Small Cell Lung Cancer Received Chemotherapy Combined with Anti-Angiogenic Therapy
00:00 - 00:00 | Presenter: LINA Zhang
- Abstract
Loading... -
+
P89.15 - Multiple Driver Oncogenes from Plasma of NSCLC Patients
00:00 - 00:00 | Presenter: Sita Andarini
- Abstract
Loading... -
+
P89.18 - Comprehensive Molecular Characterization of Chinese Patients with Oesophageal Cancer Related with Age
00:00 - 00:00 | Presenter: Lianke Liu
- Abstract
Loading...
-
+
P90 - Targeted Therapy - Clinically Focused - Misc. Topics
- Type: Posters
- Track: Targeted Therapy - Clinically Focused
- Presentations: 4
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
P90.01 - Clinical Characteristics and Outcome of Patients with Non-Small Cell Lung Cancer Harboring BRAF Mutations
00:00 - 00:00 | Presenter: mina Zhang
- Abstract
Loading... -
+
P90.02 - BRAF Mutation And Peridiagnosis Thromboembolic Events In Advanced NSCLC Patients
00:00 - 00:00 | Presenter: Inmaculada Aparicio Salcedo
- Abstract
Loading... -
+
P90.03 - A Phase 2 Trial of MRTX849 in Combination with Pembrolizumab in Patients with Advanced Non-Small Cell Lung Cancer with KRAS G12C Mutation
00:00 - 00:00 | Presenter: Alex I. Spira
- Abstract
Loading... -
+
P90.04 - RAS Precision Medicine Trans-Atlantic Partnership: Multi-Centre Pooled Analysis of RAS Pathway Mutations in Advanced NSCLC
00:00 - 00:00 | Presenter: Helen Adderley
- Abstract
Loading...
-
+
P92 - Mesothelioma, Thymoma and Other Thoracic Malignancies - Misc. Topics
- Type: Posters
- Track: Mesothelioma, Thymoma and Other Thoracic Malignancies
- Presentations: 1
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
P92.01 - Genetic Landscape and Potential Therapy Regimen of Thymic Tumor
00:00 - 00:00 | Presenter: Naixin Liang
- Abstract
Loading...
-
+
P94 - Pathology, Molecular Pathology and Diagnostic Biomarkers - Misc. Topics
- Type: Posters
- Track: Pathology, Molecular Pathology and Diagnostic Biomarkers
- Presentations: 1
- Coordinates: 1/28/2021, 00:00 - 00:00, ePoster Hall
-
+
P94.01 - Comparison of Driver Mutations in Primary and Metastatic Lung Cancer
00:00 - 00:00 | Presenter: Xin Hong
- Abstract
Loading...
-
+
PDSC01 - Product Showcase
- Type: Product Showcases
- Track: N.A.
- Presentations: 3
- Coordinates: 1/28/2021, 00:00 - 00:00, Product Theater (via Industry Hub)
-
+
PDSC01.01 - 360° Perspectives on Biomarker Testing in Non-Small Cell Lung Cancer by PFIZER
00:00 - 00:00 | Author(s): Rasheda Persinger
- Abstract
No abstract available for this presentation
-
+
PDSC01.02 - Clinical Perspectives on the use of VIZIMPRO® (dacomitinib) as a First-line Treatment for Adults with Advanced or Metastatic NSCLC with EGFR-activating Mutations by PFIZER
00:00 - 00:00 | Author(s): Federico Cappuzzo
- Abstract
No abstract available for this presentation
-
+
PDSC01.03 - A 15 Min Catch Up on New Developments in NGS for Oncologists by THERMO FISHER SCIENTIFIC
00:00 - 00:00 | Author(s): Luca Quagliata
- Abstract
No abstract available for this presentation
-
+
JICC01 - Joint IASLC-CAALC-CSCO Session: The Truth and Myth of Oral Anti-VEGFR Inhibitors for Advance NSCLC
- Type: Workshop
- Track: N.A.
- Presentations: 17
- Coordinates: 1/28/2021, 07:00 - 09:00, Scientific Program Auditorium
-
+
JICC01.01 - Chair
07:00 - 07:00 | Presenter: Yi-long Wu
- Abstract
No abstract available for this presentation
-
+
JICC01.02 - Chair
07:00 - 07:00 | Presenter: Tony S. Mok
- Abstract
No abstract available for this presentation
-
+
JICC01.03 - Chair
07:00 - 07:00 | Presenter: Chunxue Bai
- Abstract
No abstract available for this presentation
-
+
JICC01.04 - Chair
07:00 - 07:00 | Presenter: Caicun Zhou
- Abstract
No abstract available for this presentation
-
+
JICC01.05 - Single-Cell Sequencing Atlas of Tumor-associated Microvascular Endothelial Cell in Lung Cancer
07:00 - 07:15 | Presenter: Dawei Yang
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
JICC01.06 - From Antibody to Small Molecule: What is the Difference?
07:15 - 07:30 | Presenter: Heather Wakelee
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
JICC01.07 - Oral VEGFR Inhibitor Monotherapy for Lung Cancer: Should We or Should We Not?
07:30 - 07:45 | Presenter: Robert Pirker
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
JICC01.08 - Target Driver Gene and Target VEGFR: Could Prolong OS？
07:45 - 08:00 | Presenter: Ying Cheng
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
JICC01.09 - Small Molecule Anti-VEGFR Combination with PD-1/PD-L1 Blockades: New Hope?
08:00 - 08:15 | Presenter: Shengxiang Ren
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
JICC01.10 - Live Panel Discussion
08:15 - 08:25
- Abstract
No abstract available for this presentation
-
+
JICC01.11 - Icotinib versus Chemotherapy as Adjuvant Treatment for Stage II–IIIA EGFR-Mutant NSCLC (EVIDENCE): A Randomized, Open-Label, Phase 3 Study
08:25 - 08:30 | Presenter: Caicun Zhou
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
JICC01.12 - Molecular Landscape of Primary and Acquired Resistance to Immune Checkpoint Inhibitors in Chinese Advanced Non-Small Cell Lung Cancer
08:30 - 08:35 | Presenter: Xiaomin Niu
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
JICC01.13 - Discussant
08:35 - 08:40 | Presenter: Si-Yang Liu
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
JICC01.14 - Efficacy and Safety of Pralsetinib in Chinese Patients with Advanced RET Fusion+ Non-Small Cell Lung Cancer after Platinum-Based Chemotherapy
08:40 - 08:45 | Presenter: Qing Zhou
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
JICC01.15 - Pyrotinib Combined with Apatinib for HER2-Mutant Non-Small Cell Lung Cancer: Interim Analysis from a Phase II Clinical Study
08:45 - 08:50 | Author(s): Guangjian Yang
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
JICC01.16 - Discussant: The Truth and Myth of Oral Anti-VEGFR Inhibitors for Advance NSCLC
08:50 - 08:55 | Presenter: Xiaorong Dong
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
JICC01.17 - Live Panel Discussion
08:55 - 09:00
- Abstract
No abstract available for this presentation
-
+
IS01 - Satellite CME Symposium by Clinical Care Options: Advances in Antibody–Drug Conjugates for Treatment of Non-Small-Cell Lung Cancer
- Type: Satellite CME Symposia
- Track:
- Presentations: 6
- Coordinates: 1/28/2021, 09:15 - 10:15, Scientific Program Auditorium
-
+
IS01.01 - Welcome, Introduction and Baseline Assessment
09:15 - 09:20
- Abstract
No abstract available for this presentation
-
+
IS01.02 - Introduction to Novel Antibody–Drug Conjugates for Treatment of NSCLC
09:20 - 09:30
- Abstract
No abstract available for this presentation
-
+
IS01.03 - Presentation on Activity of ADCS in Clinical Trials for Lung Cancer
09:30 - 09:40
- Abstract
No abstract available for this presentation
-
+
IS01.04 - Panel Discussion and Clinical Pearls: Integrating ADC Therapy in NSCLC
09:40 - 09:55
- Abstract
No abstract available for this presentation
-
+
IS01.05 - Panel Discussion and Q&A
09:55 - 10:10
- Abstract
No abstract available for this presentation
-
+
IS01.06 - Summary, Final Thoughts, Post Education Assessment and Q&A
10:10 - 10:15
- Abstract
No abstract available for this presentation
-
+
IS02 - Industry Symposium Sponsored by AstraZeneca: Evolving the Role of Immunotherapy in Lung Cancer: ES-SCLC and Unresectable Stage III NSCLC
- Type: Industry Symposium
- Track:
- Presentations: 6
- Coordinates: 1/28/2021, 10:30 - 11:30, Industry Symposia Auditorium (via Industry Hub)
-
+
IS02.01 - Opening Remarks
10:30 - 10:35 | Presenter: Masahiro Tsuboi
- Abstract
No abstract available for this presentation
-
+
IS02.02 - Current Strategies for IO Therapy for Unresectable Stage III NSCLC
10:35 - 10:45 | Presenter: Glenwood Dillon Goss
- Abstract
No abstract available for this presentation
-
+
IS02.03 - Future Strategies: The Potential Role of IO Therapy in Unresectable Stage III NSCLC
10:45 - 10:55 | Presenter: Suresh Senan
- Abstract
No abstract available for this presentation
-
+
IS02.04 - Defining the Role of Immunotherapy in the Treatment of ES-SCLC
10:55 - 11:05 | Presenter: Myung-Ju Ahn
- Abstract
No abstract available for this presentation
-
+
IS02.05 - Emerging Biomarkers in SCLC
11:05 - 11:15 | Presenter: Charles M. Rudin
- Abstract
No abstract available for this presentation
-
+
IS02.06 - Panel Discussion / Q&A Panel Discussion
11:15 - 11:30
- Abstract
No abstract available for this presentation
-
+
IS03 - Industry Symposium Sponsored by Daiichi-Sankyo: Antibody Drug Conjugates (ADC) as Therapeutic Options for Advanced NSCLC: Opportunities and Challenges
- Type: Industry Symposium
- Track:
- Presentations: 5
- Coordinates: 1/28/2021, 11:45 - 12:45, Industry Symposia Auditorium (via Industry Hub)
-
+
IS03.01 - Welcome and Introduction
11:45 - 11:50 | Presenter: Tony S. Mok
- Abstract
No abstract available for this presentation
-
+
IS03.02 - Evolving Challenges for the Treatment of Advanced NSCLC
11:50 - 12:00 | Presenter: Tony S. Mok
- Abstract
No abstract available for this presentation
-
+
IS03.03 - Emerging ADC Targets for the Treatment of Late-Line NSCLC
12:00 - 12:15 | Presenter: Pasi Antero Jänne
- Abstract
No abstract available for this presentation
-
+
IS03.04 - ADC Therapies as Targeted Treatment Options in Patients With Advanced NSCLC
12:15 - 12:30 | Presenter: James Chih-Hsin Yang
- Abstract
No abstract available for this presentation
-
+
IS03.05 - Interactive Q&A/Panel Discussion
12:30 - 12:45
- Abstract
No abstract available for this presentation
-
+
IS04 - Industry Symposium Sponsored by Lilly Oncology: Implementing Precision Oncology in the Clinic: Diagnostic Challenges and Best Practices
- Type: Industry Symposium
- Track:
- Presentations: 7
- Coordinates: 1/28/2021, 13:00 - 14:00, Industry Symposia Auditorium (via Industry Hub)
-
+
IS04.01 - Chair’s Welcome
13:00 - 13:04 | Presenter: Koichi Goto
- Abstract
No abstract available for this presentation
-
+
IS04.02 - Introduction to the Topic - A Brief Overview of the 15-Year Journey of Biomarker Driven Management of NSCLC
13:04 - 13:10 | Presenter: Koichi Goto
- Abstract
No abstract available for this presentation
-
+
IS04.03 - Developing Best Practices for the Accurate Diagnosis and Treatment of All Patients With NSCLC - Practical Tips on Optimising Diagnostic Capabilities in the Clinic
13:10 - 13:22 | Presenter: Herbert H Loong
- Abstract
No abstract available for this presentation
-
+
IS04.04 - The Roles of the Oncologist and Pathologist in Providing an Actionable Diagnosis - Discuss the Role of the Tumour Board / MDT in Implementing Precision Medicine
13:22 - 13:34 | Presenter: Fernando Lopez-Rios
- Abstract
No abstract available for this presentation
-
+
IS04.05 - Gaining Consensus - An Overview of the IASLC, NCCN and ESMO Guidelines for Treating and Testing Patients
13:34 - 13:44 | Presenter: Giuseppe Curigliano
- Abstract
No abstract available for this presentation
-
+
IS04.06 - Panel Discussion and Q&A
13:44 - 14:00
- Abstract
No abstract available for this presentation
-
+
IS04.07 - Symposium Close
14:00 - 14:00 | Presenter: Koichi Goto
- Abstract
No abstract available for this presentation
first
prev
